Medication info
Sitagliptin 100 mg Tablets (Sitagliptin Hydrochloride Monohydrate)

Sitagliptin 100 mg Tablets (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
Pale orange, round, bi-convex, film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP × 3]
Approval status
Active

MFDS item code 202100078 · Approved 2021.01.05 · Insurance code 646005640

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered at a dose of 100 mg once daily when used as monotherapy or in combination therapy, and the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Since dosage adjustment is required according to renal function, assessment of renal function is recommended before starting this medicine and periodically during treatment. No dosage adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). In patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. In patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

  • Difficulty in blood glucose control in patients with type 2 diabetes
View approved original text

This medication is used in combination with dietary and exercise therapy to assist patients with type 2 diabetes in controlling blood sugar levels. Initially, it is given as monotherapy, and in cases where blood sugar control is difficult with monotherapy or where the patient has not previously used diabetes medications, it may be taken together with Metformin. Additionally, this medication is used in combination with sulfonylureas, Metformin, thiazolidinediones, or insulin when blood glucose control is insufficient with monotherapy. If combination therapy is not sufficiently effective, this medication may be added to improve blood glucose control. It effectively assists in controlling blood glucose levels in combination with multiple medications.

How to take

Adult dose

This medicine is administered at a dose of 100 mg once daily when used as monotherapy or in combination therapy, and the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Since dosage adjustment is required according to renal function, assessment of renal function is recommended before starting this medicine and periodically during treatment. No dosage adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). In patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. In patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication may cause allergic reactions, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, discontinue use immediately and consult a doctor. While taking this medication, there is a risk of developing acute pancreatitis, a serious inflammation of the pancreas, so it is crucial to inform healthcare professionals immediately if symptoms such as abdominal pain, vomiting, or loss of appetite appear. Patients with type 1 diabetes or diabetic ketoacidosis should not take this medication, nor should those who are allergic to this medication or its components. Patients with impaired renal function need to adjust the dosage of this medication, so regular kidney function tests should be conducted, and the advice of a doctor should be followed. Some patients reported symptoms such as cold symptoms, headaches, and digestive disorders when taking this medication alone or in combination with other diabetes medications. If these symptoms are severe, consult healthcare professionals. When taken with other hypoglycemic agents, especially insulin or sulfonylureas, there may be an increased risk of hypoglycemia, so glucose levels should be checked frequently, and immediate action should be taken if symptoms occur. If any abnormal symptoms such as severe joint pain or skin blisters occur while taking this medication, discontinue use immediately and seek consultation from a specialist. Pregnant or nursing women should avoid using this medication, and children under 18 years of age should not take it as safety and efficacy have not been established. Elderly patients are at a higher risk of impaired renal function, so dosage adjustments and regular kidney function tests are necessary. In case of overdose, general treatment such as removing the drug from the gastrointestinal tract should be performed, and if necessary, some drugs may be removed by hemodialysis. Therefore, it is essential to visit a medical facility immediately in emergency situations. This drug has relatively few interactions with other medications, but if the patient is taking certain drugs, they should inform their doctor or pharmacist.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory tract infection
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
Show 27 more
  • nausea
  • constipation
  • vomiting
  • severe and disability-related arthralgia
  • vesicular pseudoporphyria
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • increased liver enzyme levels
  • acute kidney failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased blood triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is recommended to maintain a room temperature between 1 and 30 degrees Celsius. Proper storage will help retain the medication's effectiveness over a long period.

Appearance and packaging

Appearance

Pale orange, round, bi-convex, film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP × 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.